Nelsen Robert

EDGAR CIK 0001219042

Prime Medicine, Inc. - PRME

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$10.00 M
3,030,300 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
08/01/2025
08/01/2025
Buy
3,030,300 @ $3.30
 $9,999,990 6,230,300 (94.70%) Indirect - By ARCH Venture Fund XII, L.P.